RSS   Newsletter   Contact   Advertise with us
Post Online Media

Proteome Sciences appoints Jeremy Haigh to board

Proteome SciencesProteome Sciences, a biotechnology company, announced that Jeremy Haigh will be joining the board as CEO in June.
Article continues below

READ MORE Proteome Sciences appoints Jeremy Haigh as director, CEO

Mr. Haigh is an established leader in the biopharmaceutical sector with 30 years in clinical and operational research and development, principally at Merck and Amgen where most recently he was European Chief Operating Officer, R&D.

Mr. Haigh's basic training was in neuropharmacology and he has been significantly involved in healthcare policy and government affairs in the UK and Europe having served on the board of the BioIndustry Association (BIA), the European Federation of Pharmaceutical Industries (EFPIA) Research Directors Group, and the Association of the British Pharmaceutical Industry Innovation Board (ABPI).

Mr. Haigh is currently the Chairman of Cogent Skills Limited and a member of Imperial College Health Partners Advisory Council.

 LATEST MOVES FROM United Kingdom 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy